Related to GSK Provides Free Access to Data on 13,500 Compounds with Potential against Malaria

• Sirtuins: Antiaging Medicines or Marketing?
  GSK shelled out $720 million for Sirtris but admits that the new science needs validation.
  
• Examining Both Sides of the Sirtuin Coin
  Jury is still out on whether inhibition and/or activation can treat neurodegenerative disorders.
  
• Lupus Drug Development Remains Risky Business
  Research to understand underlying causes is, nonetheless, prompting some interest.
  
• Will a Nonautologous Cancer Vaccine Be the Next to Make It Through Approval?
  In the race to mimic Dendreon’s success with Provenge, off-the-shelf products make for attractive opportunities.
  
• Exploring New Ways to Get at Old Bacterial Targets to Combat Resistant Strains
  Arsenal must include not just souped-up me toos but also some brand new compounds.
  
• Biotechs Hop on Cloud Nine with Better Resources Gained from New Technology
  Companies large and small are seeing benefits as cloud-based services get fine-tuned for the life sciences.
  
• Personalized Medicine Initiatives Step Into the Cloud to Speed Up R&D
  Drug developers see advantages in handling and interpreting data generated by large-scale next-gen sequencing.
  
• President Barack Obama’s Administration Launches Big Data Initiative with $200M
  Aim is to augment techniques for data storage, access, and interpretation.
  
• Researchers Try to Answer the Question: Is Big Data Too Big?
  Better data-handling solutions key to leveraging the omics revolution.
  
• Resolving Pharmacological Responses
  A new microfluidic approach can dramatically increase the number of data points per compound during screening.
  
• Leveraging the Cancer Transcriptome for New Drug Targets
  New analytical tools are advancing research efforts.
  
• App Connects Rare Disease Researchers to Data
  New mobile app aggregates chemistry data and other open science data to help advance research for a myriad of diseases.
  
• Are You Already Obsolete?
  To stay ahead in the ever-quickening world of research, scientists must be fast and cunning.
  
• NIH Update: Too Much Is Not Enough
  A surfeit of data and postdocs drive NIH’s new programs, but funding is uncertain.
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Cancer Model Database Emerges from WOMB
  Oncology researchers wishing for a tool to help them find available models and services may have had their prayers answered.